Healthineers buys 55,000 shares. Siemens Healthineers stock sits 15.49 percent below high

Published on 10/26/2026 at 11:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

RBC set a EUR 48.00 target on October 16, 2026. Siemens Healthineers stock costs EUR 42.00 on October 26, 2026, 0.33 percent above Xetra close.

Capital action and key dates

Siemens Healthineers bought back 55,000 shares between October 12 and October 18, 2026.
RBC raised its target to EUR 48.00 on October 16, 2026.
Siemens Healthineers stock trades at EUR 42.00 at 11:08 a.m. CET at Lang & Schwarz on October 26, 2026, 0.33 percent above the Xetra close of October 23, 2026.
Fourth-quarter results are scheduled for November 5, 2026.

Isometrische Illustration einer Diagnostik-Prozesskette mit Scanner und Labor — Siemens Healthineers DE000SHL1006 visualisiert isometrische Diagnostik-Wertschöpfungskette von Scanner über Labor bis Arztauswertung, Illustration mit AI erstellt.

Healthineers bought back 55,000 shares between October 12 and October 18, 2026, according to MarketScreener. Siemens Healthineers stock was trading at EUR 42.00 at Lang & Schwarz on October 26, 2026 at 11:08 a.m. CET, 0.33 percent above the Xetra close of October 23, 2026 at EUR 41.86.

Buyback totals 3.529 million shares

The latest purchase lifted the total bought back since June 1, 2026 to 3,529,346 shares. The transactions were executed on Xetra, giving the capital return program a visible market footprint even as the daily price move stayed below 1.00 percent.

For investors, the more important comparison is valuation against the recent trading band. The stock's 52-week range is EUR 32.81 to EUR 49.70, placing the current quote 15.49 percent below the high and 27.99 percent above the low.

Three dated steps in 2026

On July 31, 2026, Siemens Healthineers reported third-quarter revenue of EUR 5.764 billion, up 1.80 percent from the year-earlier period, while adjusted operating margin reached 19.10 percent, according to NadirAlpha. On October 16, 2026, MarketScreener reported that RBC raised its target from EUR 45.00 to EUR 48.00 and kept an Outperform rating. On October 19, 2026, the company disclosed the 55,000-share buyback tranche.

What comes next for results?

The next scheduled milestones are fourth-quarter results on November 5, 2026, followed by a US roadshow on November 6, 2026, according to the Siemens Healthineers investor-relations page. Management's fiscal-year 2026 outlook calls for comparable revenue growth of 3.50 percent to 4.00 percent and adjusted earnings per share of EUR 2.35 to EUR 2.45, with Diagnostics remaining the central operating test.

Stock stays below its yearly high

The EUR 7.70 gap to the 52-week high leaves the share below its recent peak, while the buyback provides a quantified capital-allocation signal ahead of the November results. The further course of trading is shown by the continuously updated real-time quote of Siemens Healthineers stock.